Universidade Federal de São Paulo, Bentham Brand Ambassador, Jardim Brasil, Limeira, Brazil.

Dr. Bergantin received his academic education at EPM-UNIFESP (Brazil): biomedicine (2008), MSc (2010) and PhD (2014); with a research visiting period in UAM (Spain). His research involves cell signalling mediated by Ca2+ and cAMP, including its role in neuropsychopharmacology, autonomic and cardiovascular pharmacology, and cancer. Dr. Bergantin´s research work solved the enigma of the paradoxical effects produced by L-type Ca2+ channel blockers (CCB), which was published in Cell Calcium and achieved the position ´ScienceDirect TOP 25 Hottest Articles´ (ranked #1 on the TOP 25 for Cell Calcium, 2013). This discovery generated 17 articles published in international journals indexed in PubMed, in which 14 of them Dr. Bergantin is the sole author. Dr. Bergantin is member of several editorial boards of international journals, and has been frequently invited to be honorable guest in international conferences as well as to participating in media interviews.